A detailed history of Mawer Investment Management Ltd. transactions in Johnson & Johnson stock. As of the latest transaction made, Mawer Investment Management Ltd. holds 2,503,774 shares of JNJ stock, worth $388 Million. This represents 1.9% of its overall portfolio holdings.

Number of Shares
2,503,774
Previous 2,532,433 1.13%
Holding current value
$388 Million
Previous $370 Million 9.62%
% of portfolio
1.9%
Previous 1.8%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$145.48 - $167.38 $4.17 Million - $4.8 Million
-28,659 Reduced 1.13%
2,503,774 $406 Million
Q2 2024

Aug 07, 2024

SELL
$144.38 - $157.78 $63.8 Million - $69.8 Million
-442,106 Reduced 14.86%
2,532,433 $370 Million
Q1 2024

May 06, 2024

SELL
$155.22 - $162.74 $1.57 Million - $1.65 Million
-10,123 Reduced 0.34%
2,974,539 $471 Million
Q4 2023

Feb 07, 2024

SELL
$145.6 - $158.88 $56.2 Million - $61.3 Million
-385,765 Reduced 11.45%
2,984,662 $468 Million
Q3 2023

Nov 06, 2023

SELL
$155.75 - $174.48 $145 Million - $163 Million
-932,862 Reduced 21.68%
3,370,427 $525 Million
Q2 2023

Aug 09, 2023

SELL
$154.35 - $166.11 $5.78 Million - $6.22 Million
-37,470 Reduced 0.86%
4,303,289 $712 Million
Q1 2023

May 05, 2023

SELL
$151.05 - $180.26 $5.87 Million - $7 Million
-38,852 Reduced 0.89%
4,340,759 $673 Million
Q4 2022

Feb 07, 2023

BUY
$160.2 - $179.79 $25.7 Million - $28.8 Million
160,427 Added 3.8%
4,379,611 $774 Million
Q3 2022

Nov 09, 2022

SELL
$161.33 - $179.52 $2.57 Million - $2.86 Million
-15,914 Reduced 0.38%
4,219,184 $689 Million
Q2 2022

Aug 09, 2022

SELL
$168.19 - $186.01 $1.15 Million - $1.27 Million
-6,827 Reduced 0.16%
4,235,098 $752 Million
Q1 2022

May 06, 2022

BUY
$158.14 - $179.59 $12.7 Million - $14.4 Million
80,228 Added 1.93%
4,241,925 $752 Million
Q4 2021

Feb 09, 2022

SELL
$155.93 - $173.01 $13.9 Million - $15.5 Million
-89,372 Reduced 2.1%
4,161,697 $712 Million
Q3 2021

Nov 10, 2021

BUY
$161.5 - $179.47 $38 Million - $42.2 Million
235,217 Added 5.86%
4,251,069 $687 Million
Q2 2021

Aug 11, 2021

BUY
$159.48 - $171.07 $27.9 Million - $30 Million
175,118 Added 4.56%
4,015,852 $662 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $29.1 Million - $32.4 Million
190,126 Added 5.21%
3,840,734 $631 Million
Q4 2020

Feb 09, 2021

BUY
$137.11 - $157.38 $21.1 Million - $24.2 Million
154,006 Added 4.4%
3,650,608 $574 Million
Q3 2020

Nov 13, 2020

BUY
$140.38 - $153.83 $15.4 Million - $16.9 Million
110,028 Added 3.25%
3,496,602 $516 Million
Q2 2020

Aug 10, 2020

BUY
$128.81 - $155.51 $12.5 Million - $15 Million
96,733 Added 2.94%
3,386,574 $476 Million
Q1 2020

May 07, 2020

BUY
$111.14 - $153.99 $103 Million - $142 Million
924,358 Added 39.08%
3,289,841 $432 Million
Q4 2019

Feb 10, 2020

BUY
$127.5 - $146.44 $26 Million - $29.9 Million
204,112 Added 9.44%
2,365,483 $345 Million
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $9.41 Million - $10.5 Million
74,129 Added 3.55%
2,161,371 $280 Million
Q2 2019

Aug 06, 2019

BUY
$131.15 - $144.24 $16 Million - $17.6 Million
122,143 Added 6.22%
2,087,242 $291 Million
Q1 2019

May 09, 2019

BUY
$125.72 - $139.79 $29.5 Million - $32.8 Million
234,310 Added 13.54%
1,965,099 $275 Million
Q4 2018

Feb 12, 2019

BUY
$122.84 - $147.84 $25.8 Million - $31 Million
209,683 Added 13.78%
1,730,789 $223 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $7.78 Million - $9.14 Million
63,950 Added 4.39%
1,521,106 $210 Million
Q2 2018

Aug 08, 2018

BUY
$119.4 - $131.76 $4.6 Million - $5.07 Million
38,500 Added 2.71%
1,457,156 $177 Million
Q1 2018

May 07, 2018

BUY
$125.1 - $148.14 $2.24 Million - $2.66 Million
17,929 Added 1.28%
1,418,656 $182 Million
Q4 2017

Feb 09, 2018

BUY
$131.22 - $143.62 $679,588 - $743,807
5,179 Added 0.37%
1,400,727 $196 Million
Q3 2017

Nov 08, 2017

BUY
$129.47 - $135.38 $181 Million - $189 Million
1,395,548
1,395,548 $181 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Mawer Investment Management Ltd. Portfolio

Follow Mawer Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mawer Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mawer Investment Management Ltd. with notifications on news.